Novartis receives EC Approval for Beovu, a next-generation anti-VEGF treatment for wet AMD, a…
Novartis announced the European Commission (EC) has approved Beovu (brolucizumab) injection for the treatment of wet age-related macular degeneration (AMD). Beovu is the first…
Read More...
Read More...
